$MDCX Balance Sheet | Understand Stock

$MDCX

$2.48 +$0.03 (1.22%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
Assets
Current assets
Cash and cash equivalents
Prepaid expenses and other current assets
Deferred financing costs
Total current assets
Restricted cash
Operating lease right-of-use assets
Deferred issuance costs
Total assets
Liabilities and Shareholder's equity
Current liabilities
Accounts payable
Accrued expenses and other current liabilities
Related party payable
Operating lease liability, current
Debentures
Debentures and secured promissory notes, current
Total current liabilities
Debentures and secured promissory notes, non-current
Loan payable
Operating lease liability, non-current
Total liabilities
Shareholders' (deficit) equity
Common shares, no par value; unlimited shares authorized; 60,168,044 and 25,176,303 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively
Common shares to be issued
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Total shareholders' (deficit) equity attributable to Medicus Pharma Ltd.
Non-controlling interests
Total shareholders' (deficit) equity
Total liabilities and shareholders' (deficit) equity

Comments